We have the right people to develop the right solution for the right therapy.
Istvan Petak, MD, PhD
CEO, CSO & Founder
Dr. Istvan Petak is an international expert in precision oncology and molecular pharmacology of targeted therapies with 25+ years of experience. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC). He started his molecular pathology and signal transduction therapy career at Semmelweis University and St. Jude Children's Research Hospital (Memphis, TN). His main achievements are exploring the role of apoptotic pathways in individual drug sensitivity, pioneering molecular companion diagnostics of the EGFR gene in 2003, and implementing NGS (next-generation sequencing) in precision oncology in 2008. He is the lead inventor of a novel computational method, published in 2021, for standardized, personalized treatment recommendations that has won numerous recognitions from organizations, including DIGITALEUROPE and ASCO.
Irving Levy, CPA
President & CCO
Mr. Levy is an accomplished entrepreneur, financial leader, and philanthropist with a 40-year career. He currently serves as President of Genomate Health, Inc. and Executive Director of the Foundation for Jewish Philanthropies. As a founding member of Exigence Group, a physician practice management start-up, Mr. Levy’s financial expertise led to remarkable growth, culminating in a $120 million expansion and exit in seven years in a sale to TeamHealth, a prominent public company owned by Blackstone Private Equity. Mr. Levy actively invests in early-stage enterprises as a General Partner in Impact Capital LLC, Buffalo Capital Partners LLC, and CPB Holdings Solutions, LLC.Mr. Levy was a Director and Partner of a Top 100 US public accounting firm, specializing in tax, healthcare, and entrepreneurial advisory services.
Mr. Levy’s extensive board involvement showcases his leadership capabilities and commitment to making a positive impact on the community.
Ioana Stupariu, LLM
Chief of Staff & Head of Legal
Ms. Stupariu is a technology regulation expert, with 15 years of experience in project management and operations and academic background in international business law. She founded ReadyTech Consulting, a boutique consultancy focused on providing regulatory, legal & compliance support to SMEs and is now an advisor for multiple technology driven startups in the region. Her professional portfolio also includes being Country Data Protection Officer for a large automotive company (responsible for 8 legal entities and 19.000 employees) and assistant professor of EU and International Law for 400- law student cohorts. Her PhD research at Central European University, Columbia Law School and China University of Political Science and Law allowed her to study applied privacy and technology in depth. As a project and event manager, she has organized over 100 international events. She founded and coordinated an entrepreneurship social inclusion program for youth with thousands of beneficiaries (YouthBank Romania), and then an international academic network with members in 15 European countries and managed a team of 50 members (Lawyr.it).
Sean Khozin, MD, MPH
Advisor on Medical Affairs & Regulatory Strategy
Dr. Sean Khozin is a globally recognized oncologist, data scientist, and physician-executive with extensive experience in therapeutic development and AI applications in biomedical research. As the founder of Phyusion and Senior Partner at Braven, he focuses on advancing innovations at the nexus of biology, technology, and AI. Previously, he was the CEO of CancerLinQ, the Global Head of Data Strategy at Johnson & Johnson, and a founding member of the US FDA’s Oncology Center of Excellence in addition to serving as the founding executive director of INFORMED, FDA’s first science and technology incubator. Dr. Khozin is the cofounder of the technology company Hello Health and founder of SKMD, a multidisciplinary network of clinics utilizing telemedicine and remote monitoring tools to improve patient outcomes. He is a Research Affiliate at MIT and started his clinical research work at the US National Cancer Institute developing molecular profiling strategies in thoracic malignancies.
Dr. Khozin’s board appointments include the Society for Translational Oncology, Alliance for AI in Healthcare, Digital Medicine Society, and the CEO Roundtable on Cancer’s Life Sciences Council.
At Genomate Health, our leadership team is made up of industry leaders, senior innovators, and smart advisory specialists who are passionate about making a positive impact in the world.
With their combined decades of experience in healthcare, technology, and business, our team is dedicated to transforming cancer care and improving outcomes for all patients.
Dr. Olivia Morgan
AI Oncology Expert
Dr. Morgan is a leading expert in the field of AI and oncology. With extensive experience in developing and implementing AI algorithms for cancer detection and treatment, she advises the biotech company on leveraging AI technologies to analyze complex patient data, identify biomarkers, and improve precision medicine approaches in oncology.
Professor Alexei Petrov
Computational Genomics Advisor
Professor Petrov is a renowned academic specializing in computational genomics and cancer biology. His expertise lies in analyzing genomic data to unravel the underlying mechanisms of cancer and develop personalized treatment strategies.
Dr. Sophia Ramirez
Machine Learning and Imaging Specialist
Dr. Ramirez is an expert in machine learning and medical imaging analysis. She focuses on developing innovative algorithms that leverage imaging data to aid in cancer diagnosis, treatment planning, and monitoring. Her role on the scientific advisory board is to provide insights on optimizing AI-driven imaging technologies for oncology applications.
Dr. Rachel Patel
Dr. Patel is a practicing medical oncologist with extensive experience in treating cancer patients. Her role on the advisory board is to provide guidance on the clinical applications of AI technologies in oncology, ensuring that the biotech company's research aligns with the needs and requirements of patients and healthcare providers.
Professor John Kim
Professor Kim is an expert in medical ethics, with a focus on the ethical implications of AI in healthcare. His role on the advisory board is to ensure that the biotech company's AI-driven research and development processes are aligned with ethical and regulatory standards, and that patient privacy and safety are prioritized.
Dr. Maria Hernandez
Dr. Hernandez is a patient advocate and cancer survivor who provides a patient's perspective on the biotech company's AI-driven research. Her role on the advisory board is to ensure that the company's work is patient-centric, addresses unmet patient needs, and is accessible to diverse patient populations.
Dr. Emily Chen
Dr. Chen is a renowned oncologist who has dedicated her career to cancer research and philanthropy. As an investor and board member, she supports the biotech company's mission to advance AI research in oncology and contributes her medical insights and network to accelerate breakthrough discoveries.
Mr. Jonathan Anderson
Venture Capital Partner
Mr. Anderson is a seasoned venture capital partner with a strong background in biotech investments. He brings his financial expertise and industry knowledge to the board, providing strategic guidance on funding, business development, and growth opportunities for the biotech company.
Let’s outsmart cancer. Together.
If you are looking for a challenging and fulfilling career that makes a difference in the world, join us at Genomate Health and be a part of a team that is revolutionizing cancer treatment.